🇺🇸 Glifage in United States

2,332 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 2,332

Most-reported reactions

1. Malaise — 305 reports (13.08%)
2. Drug Ineffective — 288 reports (12.35%)
3. Blood Glucose Increased — 277 reports (11.88%)
4. Pain — 251 reports (10.76%)
5. Weight Decreased — 245 reports (10.51%)
6. Pain In Extremity — 201 reports (8.62%)
7. Diarrhoea — 197 reports (8.45%)
8. Diabetes Mellitus — 191 reports (8.19%)
9. Nausea — 189 reports (8.1%)
10. Dizziness — 188 reports (8.06%)

Source database →

Frequently asked questions

Is Glifage approved in United States?

Glifage does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Glifage in United States?

Biocinese is the originator. The local marketing authorisation holder may differ — check the official source linked above.